Virus News and Research

Latest Virus News and Research

Virally mediated gene therapy could potentially treat genetic hearing loss

By 2050, one in 10 individuals are expected to live with some form of hearing loss. Of the hundreds of millions of cases of hearing loss affecting individuals worldwide, genetic hearing loss is often the most difficult to treat.

26 May 2023

MHRA authorizes new COVID-19 vaccine from SK Chemicals

SKYCovion, the COVID-19 vaccine developed by SK Chemicals, has today been authorized by the Medicines and Healthcare products Regulatory Agency (MHRA).

26 May 2023

Large study uncovers new details about long COVID

Initial findings from a study of nearly 10,000 Americans, many of whom had COVID-19, have uncovered new details about long COVID, the post-infection set of conditions that can affect nearly every tissue and organ in the body.

26 May 2023

Top-Down Proteomics: Bridging the Genotype-to-Phenotype Gap

In this interview conducted at Pittcon 2023 in Philadelphia, Pennsylvania, we spoke to this year's recipient of the Pittsburgh Analytical Chemistry Award, Neil Kelleher, about his work in top-down proteinomics.

From Pittcon 26 May 2023

The potential clinical benefit of the Multabody platform as a therapeutic for SARS-CoV-2

The potential clinical benefit of the Multabody platform as a therapeutic for SARS-CoV-2.

26 May 2023

How do the outcomes of viral coinfections vary across host species?

In a recent study published in the journal PLOS Pathogens, researchers investigated the outcomes of coinfections of two viruses — Drosophila C Virus (DCV) and Cricket Paralysis Virus (CrPV) in 25 inbred lines of Drosophila melanogaster and 47 other host species belonging to the Drosophilidae family.

26 May 2023

RECOVER study: An important step toward defining long COVID

A study led by the National Institutes of Health's RECOVER Initiative and supported by NYU Langone Health, home to the effort's Clinical Science Core (CSC), provides an expanded working definition of long COVID.

25 May 2023

Nonhuman primate study helps explain how stem cell transplantation can kill HIV virus

New animal research is helping explain why at least five people have become HIV-free after receiving a stem cell transplant.

25 May 2023

Immune cells targeting core protein play an important role in early immune defense against COVID-19

LMU immunologists have studied the early immune response to acute SARS-CoV-2 infection and show how vaccines could be improved in future.

25 May 2023

The first thousand days of development

Study provides a bird's-eye view of the significant moments of the first thousand days of life.

25 May 2023

Exercise capacity found to be lower than expected among people with long COVID

While some patients recover from the effects of SARS-CoV-2 infection, others have experienced the aftereffects of COVID-19 long after the initial infection. One of these long COVID symptoms is reduced exercise capacity.

25 May 2023

Unstable housing fuels risky behaviors among US high school students, CDC study warns

Youths experiencing unstable housing face elevated health risks, including poor physical and mental health outcomes. Disproportionate burden is observed among youths of color and sexual minority youths.

24 May 2023

Long-term exposure to air pollution associated with higher risk of developing severe COVID-19

A long history of exposure to air pollution is associated with a higher risk of developing severe disease, admission to hospital or an intensive care unit (ICU) and death by COVID‑19 according to a study led by the Barcelona Institute for Global Health (ISGlobal), a research centre supported by the "la Caixa" Foundation.

24 May 2023

SARS-CoV-2 infection linked to increased risk of type 1 diabetes in children

Different studies have documented an increased incidence of type 1 diabetes during the COVID-19 pandemic.

24 May 2023

The adaptive immunity of human endemic viruses

Researchers studied the evolution of the ability of viruses to evade the neutralizing antibodies.

24 May 2023

CDC reports on its Mpox response

Research paper provides an overview of the U.S. monkeypox outbreak, highlighting the rapid response, vaccination efforts, and racial disparities in cases. Ongoing surveillance, vaccination, and communication are emphasized as crucial for future prevention.

24 May 2023

Unraveling the Epstein-Barr virus enigma: The puzzling role in multiple sclerosis development

Epstein-Barr virus (EBV) has a significant role in the development of multiple sclerosis (MS), with evidence linking EBV infection to increased MS risk and immune dysregulation. Understanding the mechanisms underlying this connection is crucial for advancing MS therapies and prevention strategies.

24 May 2023